Literature DB >> 22369786

Hypothalamic neuropeptides and the regulation of appetite.

Jennifer A Parker1, Stephen R Bloom.   

Abstract

Neuropeptides released by hypothalamic neurons play a major role in the regulation of feeding, acting both within the hypothalamus, and at other appetite regulating centres throughout the brain. Where classical neurotransmitters signal only within synapses, neuropeptides diffuse over greater distances affecting both nearby and distant neurons expressing the relevant receptors, which are often extrasynaptic. As well as triggering a behavioural output, neuropeptides also act as neuromodulators: altering the response of neurons to both neurotransmitters and circulating signals of nutrient status. The mechanisms of action of hypothalamic neuropeptides with established roles in feeding, including melanin-concentrating hormone (MCH), the orexins, α-melanocyte stimulating hormone (α-MSH), agouti-gene related protein (AgRP), neuropeptide Y, and oxytocin, are reviewed in this article, with emphasis laid on both their effects on appetite regulating centres throughout the brain, and on examining the evidence for their physiological roles. In addition, evidence for the involvement of several putative appetite regulating hypothalamic neuropeptides is assessed including, ghrelin, cocaine and amphetamine-regulated transcript (CART), neuropeptide W and the galanin-like peptides. This article is part of a Special Issue entitled 'Central control of Food Intake'.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22369786     DOI: 10.1016/j.neuropharm.2012.02.004

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  61 in total

1.  Gad1 mRNA as a reliable indicator of altered GABA release from orexigenic neurons in the hypothalamus.

Authors:  Matthew S Dicken; Alexander R Hughes; Shane T Hentges
Journal:  Eur J Neurosci       Date:  2015-10-19       Impact factor: 3.386

Review 2.  Counterregulation of insulin by leptin as key component of autonomic regulation of body weight.

Authors:  Katarina T Borer
Journal:  World J Diabetes       Date:  2014-10-15

Review 3.  Obesity: Current and potential pharmacotherapeutics and targets.

Authors:  Vidya Narayanaswami; Linda P Dwoskin
Journal:  Pharmacol Ther       Date:  2016-10-20       Impact factor: 12.310

Review 4.  Fetal alcohol programming of hypothalamic proopiomelanocortin system by epigenetic mechanisms and later life vulnerability to stress.

Authors:  Rola Bekdash; Changqing Zhang; Dipak Sarkar
Journal:  Alcohol Clin Exp Res       Date:  2014-07-28       Impact factor: 3.455

5.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

6.  Knockdown of the transcript of ERK in the brain modulates hypothalamic neuropeptide-mediated appetite control in amphetamine-treated rats.

Authors:  Ching-Han Yu; Yih-Shou Hsieh; Pei-Ni Chen; Jeng-Rung Chen; Dong-Yih Kuo
Journal:  Br J Pharmacol       Date:  2018-01-11       Impact factor: 8.739

7.  LGR4 and its ligands, R-spondin 1 and R-spondin 3, regulate food intake in the hypothalamus of male rats.

Authors:  Ji-Yao Li; Biaoxin Chai; Weizhen Zhang; Danielle M Fritze; Chao Zhang; Michael W Mulholland
Journal:  Endocrinology       Date:  2013-11-26       Impact factor: 4.736

8.  Central CRTH2, a second prostaglandin D2 receptor, mediates emotional impairment in the lipopolysaccharide and tumor-induced sickness behavior model.

Authors:  Ryota Haba; Norihito Shintani; Yusuke Onaka; Takuya Kanoh; Hyper Wang; Risa Takenaga; Atsuko Hayata; Hiroyuki Hirai; Kin-ya Nagata; Masataka Nakamura; Atsushi Kasai; Ryota Hashimoto; Kazuki Nagayasu; Takanobu Nakazawa; Hitoshi Hashimoto; Akemichi Baba
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

9.  Hindbrain dorsal vagal complex AMPK controls hypothalamic gluco-regulatory transmitter and counter-regulatory hormone responses to hypoglycemia.

Authors:  Santosh K Mandal; Karen P Briski
Journal:  Brain Res Bull       Date:  2018-11-24       Impact factor: 4.077

10.  Dynamic kisspeptin receptor trafficking modulates kisspeptin-mediated calcium signaling.

Authors:  Le Min; Kathleen Soltis; Ana Claudia S Reis; Shuyun Xu; Wendy Kuohung; Manisha Jain; Rona S Carroll; Ursula B Kaiser
Journal:  Mol Endocrinol       Date:  2013-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.